Three free access papers from the online first section of the Journal of Infectious Diseases. The articles highlight the role of CCR5 – better known as a co-receptor for HIV entry into cells – in T cell trafficking to sites of infection and suggest that studies are needed to evaluate the effects of pharmacological inhibition of CCR5 in these settings.
A Moving Target: The Multiple Roles of CCR5 in Infectious Diseases
Robyn S. Klein
Genetic Deficiency of Chemokine Receptor CCR5 Is a Strong Risk Factor for Symptomatic West Nile Virus Infection: A Meta‐Analysis of 4 Cohorts in the US Epidemic
Jean K. Lim, Christine Y. Louie, Carol Glaser, Cynthia Jean, Bernard Johnson, Hope Johnson, David H. McDermott, and Philip M. Murphy
A Deletion in the Chemokine Receptor 5 (CCR5) Gene Is Associated with Tickborne Encephalitis
Elin Kindberg, Auksė Mickienė, Cecilia Ax, Britt Åkerlind, Sirkka Vene, Lars Lindquist, Åke Lundkvist, and Lennart Svensson
Leave a Reply